Medical Care

Global Therapeutic Antibody Discovery Services Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Therapeutic Antibody Discovery Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Antibody Discovery Services.
The Therapeutic Antibody Discovery Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Antibody Discovery Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Antibody Discovery Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocytogen
Charles River Laboratories
Abcam
Alloy Therapeutics
Creative Biolabs
Twist Bioscience
Rapid Novor
Curia
AlivaMab Biologics
Integrated DNA Technologies
Antibody Solutions
Eurofins Discovery
GenScript
Evotec
Aurigene Pharmaceutical Services
Yumab
Creative Bioarray
CD ComputaBio
Biomolecular Discovery Services
ProteoGenix
Sichuan NB Biolab
Viva Biotech
SAFE Pharmaceutical Technology
Shanghai Medicilon
WuXi Biologics
XtalPi
Detaibio
Cusabio
Segment by Type
Discovery of CAR-T Antibody Drugs
Discovery of Monoclonal Antibody Drugs
Discovery of ADC Antibody Drugs
Others
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Antibody Discovery Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Antibody Discovery Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Discovery of CAR-T Antibody Drugs
1.2.3 Discovery of Monoclonal Antibody Drugs
1.2.4 Discovery of ADC Antibody Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Therapeutic Antibody Discovery Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Antibody Discovery Services Market Perspective (2020-2031)
2.2 Global Therapeutic Antibody Discovery Services Growth Trends by Region
2.2.1 Global Therapeutic Antibody Discovery Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Therapeutic Antibody Discovery Services Historic Market Size by Region (2020-2025)
2.2.3 Therapeutic Antibody Discovery Services Forecasted Market Size by Region (2026-2031)
2.3 Therapeutic Antibody Discovery Services Market Dynamics
2.3.1 Therapeutic Antibody Discovery Services Industry Trends
2.3.2 Therapeutic Antibody Discovery Services Market Drivers
2.3.3 Therapeutic Antibody Discovery Services Market Challenges
2.3.4 Therapeutic Antibody Discovery Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Antibody Discovery Services Players by Revenue
3.1.1 Global Top Therapeutic Antibody Discovery Services Players by Revenue (2020-2025)
3.1.2 Global Therapeutic Antibody Discovery Services Revenue Market Share by Players (2020-2025)
3.2 Global Therapeutic Antibody Discovery Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Therapeutic Antibody Discovery Services Revenue
3.4 Global Therapeutic Antibody Discovery Services Market Concentration Ratio
3.4.1 Global Therapeutic Antibody Discovery Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Antibody Discovery Services Revenue in 2024
3.5 Global Key Players of Therapeutic Antibody Discovery Services Head office and Area Served
3.6 Global Key Players of Therapeutic Antibody Discovery Services, Product and Application
3.7 Global Key Players of Therapeutic Antibody Discovery Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Antibody Discovery Services Breakdown Data by Type
4.1 Global Therapeutic Antibody Discovery Services Historic Market Size by Type (2020-2025)
4.2 Global Therapeutic Antibody Discovery Services Forecasted Market Size by Type (2026-2031)
5 Therapeutic Antibody Discovery Services Breakdown Data by Application
5.1 Global Therapeutic Antibody Discovery Services Historic Market Size by Application (2020-2025)
5.2 Global Therapeutic Antibody Discovery Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Therapeutic Antibody Discovery Services Market Size (2020-2031)
6.2 North America Therapeutic Antibody Discovery Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Therapeutic Antibody Discovery Services Market Size by Country (2020-2025)
6.4 North America Therapeutic Antibody Discovery Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Antibody Discovery Services Market Size (2020-2031)
7.2 Europe Therapeutic Antibody Discovery Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Therapeutic Antibody Discovery Services Market Size by Country (2020-2025)
7.4 Europe Therapeutic Antibody Discovery Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Antibody Discovery Services Market Size (2020-2031)
8.2 Asia-Pacific Therapeutic Antibody Discovery Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Therapeutic Antibody Discovery Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Therapeutic Antibody Discovery Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Antibody Discovery Services Market Size (2020-2031)
9.2 Latin America Therapeutic Antibody Discovery Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Therapeutic Antibody Discovery Services Market Size by Country (2020-2025)
9.4 Latin America Therapeutic Antibody Discovery Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Antibody Discovery Services Market Size (2020-2031)
10.2 Middle East & Africa Therapeutic Antibody Discovery Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Therapeutic Antibody Discovery Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Therapeutic Antibody Discovery Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocytogen
11.1.1 Biocytogen Company Details
11.1.2 Biocytogen Business Overview
11.1.3 Biocytogen Therapeutic Antibody Discovery Services Introduction
11.1.4 Biocytogen Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.1.5 Biocytogen Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Details
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Therapeutic Antibody Discovery Services Introduction
11.2.4 Charles River Laboratories Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.2.5 Charles River Laboratories Recent Development
11.3 Abcam
11.3.1 Abcam Company Details
11.3.2 Abcam Business Overview
11.3.3 Abcam Therapeutic Antibody Discovery Services Introduction
11.3.4 Abcam Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.3.5 Abcam Recent Development
11.4 Alloy Therapeutics
11.4.1 Alloy Therapeutics Company Details
11.4.2 Alloy Therapeutics Business Overview
11.4.3 Alloy Therapeutics Therapeutic Antibody Discovery Services Introduction
11.4.4 Alloy Therapeutics Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.4.5 Alloy Therapeutics Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Details
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs Therapeutic Antibody Discovery Services Introduction
11.5.4 Creative Biolabs Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.5.5 Creative Biolabs Recent Development
11.6 Twist Bioscience
11.6.1 Twist Bioscience Company Details
11.6.2 Twist Bioscience Business Overview
11.6.3 Twist Bioscience Therapeutic Antibody Discovery Services Introduction
11.6.4 Twist Bioscience Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.6.5 Twist Bioscience Recent Development
11.7 Rapid Novor
11.7.1 Rapid Novor Company Details
11.7.2 Rapid Novor Business Overview
11.7.3 Rapid Novor Therapeutic Antibody Discovery Services Introduction
11.7.4 Rapid Novor Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.7.5 Rapid Novor Recent Development
11.8 Curia
11.8.1 Curia Company Details
11.8.2 Curia Business Overview
11.8.3 Curia Therapeutic Antibody Discovery Services Introduction
11.8.4 Curia Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.8.5 Curia Recent Development
11.9 AlivaMab Biologics
11.9.1 AlivaMab Biologics Company Details
11.9.2 AlivaMab Biologics Business Overview
11.9.3 AlivaMab Biologics Therapeutic Antibody Discovery Services Introduction
11.9.4 AlivaMab Biologics Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.9.5 AlivaMab Biologics Recent Development
11.10 Integrated DNA Technologies
11.10.1 Integrated DNA Technologies Company Details
11.10.2 Integrated DNA Technologies Business Overview
11.10.3 Integrated DNA Technologies Therapeutic Antibody Discovery Services Introduction
11.10.4 Integrated DNA Technologies Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.10.5 Integrated DNA Technologies Recent Development
11.11 Antibody Solutions
11.11.1 Antibody Solutions Company Details
11.11.2 Antibody Solutions Business Overview
11.11.3 Antibody Solutions Therapeutic Antibody Discovery Services Introduction
11.11.4 Antibody Solutions Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.11.5 Antibody Solutions Recent Development
11.12 Eurofins Discovery
11.12.1 Eurofins Discovery Company Details
11.12.2 Eurofins Discovery Business Overview
11.12.3 Eurofins Discovery Therapeutic Antibody Discovery Services Introduction
11.12.4 Eurofins Discovery Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.12.5 Eurofins Discovery Recent Development
11.13 GenScript
11.13.1 GenScript Company Details
11.13.2 GenScript Business Overview
11.13.3 GenScript Therapeutic Antibody Discovery Services Introduction
11.13.4 GenScript Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.13.5 GenScript Recent Development
11.14 Evotec
11.14.1 Evotec Company Details
11.14.2 Evotec Business Overview
11.14.3 Evotec Therapeutic Antibody Discovery Services Introduction
11.14.4 Evotec Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.14.5 Evotec Recent Development
11.15 Aurigene Pharmaceutical Services
11.15.1 Aurigene Pharmaceutical Services Company Details
11.15.2 Aurigene Pharmaceutical Services Business Overview
11.15.3 Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Introduction
11.15.4 Aurigene Pharmaceutical Services Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.15.5 Aurigene Pharmaceutical Services Recent Development
11.16 Yumab
11.16.1 Yumab Company Details
11.16.2 Yumab Business Overview
11.16.3 Yumab Therapeutic Antibody Discovery Services Introduction
11.16.4 Yumab Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.16.5 Yumab Recent Development
11.17 Creative Bioarray
11.17.1 Creative Bioarray Company Details
11.17.2 Creative Bioarray Business Overview
11.17.3 Creative Bioarray Therapeutic Antibody Discovery Services Introduction
11.17.4 Creative Bioarray Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.17.5 Creative Bioarray Recent Development
11.18 CD ComputaBio
11.18.1 CD ComputaBio Company Details
11.18.2 CD ComputaBio Business Overview
11.18.3 CD ComputaBio Therapeutic Antibody Discovery Services Introduction
11.18.4 CD ComputaBio Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.18.5 CD ComputaBio Recent Development
11.19 Biomolecular Discovery Services
11.19.1 Biomolecular Discovery Services Company Details
11.19.2 Biomolecular Discovery Services Business Overview
11.19.3 Biomolecular Discovery Services Therapeutic Antibody Discovery Services Introduction
11.19.4 Biomolecular Discovery Services Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.19.5 Biomolecular Discovery Services Recent Development
11.20 ProteoGenix
11.20.1 ProteoGenix Company Details
11.20.2 ProteoGenix Business Overview
11.20.3 ProteoGenix Therapeutic Antibody Discovery Services Introduction
11.20.4 ProteoGenix Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.20.5 ProteoGenix Recent Development
11.21 Sichuan NB Biolab
11.21.1 Sichuan NB Biolab Company Details
11.21.2 Sichuan NB Biolab Business Overview
11.21.3 Sichuan NB Biolab Therapeutic Antibody Discovery Services Introduction
11.21.4 Sichuan NB Biolab Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.21.5 Sichuan NB Biolab Recent Development
11.22 Viva Biotech
11.22.1 Viva Biotech Company Details
11.22.2 Viva Biotech Business Overview
11.22.3 Viva Biotech Therapeutic Antibody Discovery Services Introduction
11.22.4 Viva Biotech Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.22.5 Viva Biotech Recent Development
11.23 SAFE Pharmaceutical Technology
11.23.1 SAFE Pharmaceutical Technology Company Details
11.23.2 SAFE Pharmaceutical Technology Business Overview
11.23.3 SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Introduction
11.23.4 SAFE Pharmaceutical Technology Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.23.5 SAFE Pharmaceutical Technology Recent Development
11.24 Shanghai Medicilon
11.24.1 Shanghai Medicilon Company Details
11.24.2 Shanghai Medicilon Business Overview
11.24.3 Shanghai Medicilon Therapeutic Antibody Discovery Services Introduction
11.24.4 Shanghai Medicilon Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.24.5 Shanghai Medicilon Recent Development
11.25 WuXi Biologics
11.25.1 WuXi Biologics Company Details
11.25.2 WuXi Biologics Business Overview
11.25.3 WuXi Biologics Therapeutic Antibody Discovery Services Introduction
11.25.4 WuXi Biologics Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.25.5 WuXi Biologics Recent Development
11.26 XtalPi
11.26.1 XtalPi Company Details
11.26.2 XtalPi Business Overview
11.26.3 XtalPi Therapeutic Antibody Discovery Services Introduction
11.26.4 XtalPi Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.26.5 XtalPi Recent Development
11.27 Detaibio
11.27.1 Detaibio Company Details
11.27.2 Detaibio Business Overview
11.27.3 Detaibio Therapeutic Antibody Discovery Services Introduction
11.27.4 Detaibio Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.27.5 Detaibio Recent Development
11.28 Cusabio
11.28.1 Cusabio Company Details
11.28.2 Cusabio Business Overview
11.28.3 Cusabio Therapeutic Antibody Discovery Services Introduction
11.28.4 Cusabio Revenue in Therapeutic Antibody Discovery Services Business (2020-2025)
11.28.5 Cusabio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Therapeutic Antibody Discovery Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Discovery of CAR-T Antibody Drugs
Table 3. Key Players of Discovery of Monoclonal Antibody Drugs
Table 4. Key Players of Discovery of ADC Antibody Drugs
Table 5. Key Players of Others
Table 6. Global Therapeutic Antibody Discovery Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Therapeutic Antibody Discovery Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Therapeutic Antibody Discovery Services Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Therapeutic Antibody Discovery Services Market Share by Region (2020-2025)
Table 10. Global Therapeutic Antibody Discovery Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Therapeutic Antibody Discovery Services Market Share by Region (2026-2031)
Table 12. Therapeutic Antibody Discovery Services Market Trends
Table 13. Therapeutic Antibody Discovery Services Market Drivers
Table 14. Therapeutic Antibody Discovery Services Market Challenges
Table 15. Therapeutic Antibody Discovery Services Market Restraints
Table 16. Global Therapeutic Antibody Discovery Services Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Therapeutic Antibody Discovery Services Market Share by Players (2020-2025)
Table 18. Global Top Therapeutic Antibody Discovery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Antibody Discovery Services as of 2024)
Table 19. Ranking of Global Top Therapeutic Antibody Discovery Services Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Therapeutic Antibody Discovery Services Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Therapeutic Antibody Discovery Services, Headquarters and Area Served
Table 22. Global Key Players of Therapeutic Antibody Discovery Services, Product and Application
Table 23. Global Key Players of Therapeutic Antibody Discovery Services, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Therapeutic Antibody Discovery Services Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Therapeutic Antibody Discovery Services Revenue Market Share by Type (2020-2025)
Table 27. Global Therapeutic Antibody Discovery Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Therapeutic Antibody Discovery Services Revenue Market Share by Type (2026-2031)
Table 29. Global Therapeutic Antibody Discovery Services Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Therapeutic Antibody Discovery Services Revenue Market Share by Application (2020-2025)
Table 31. Global Therapeutic Antibody Discovery Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Therapeutic Antibody Discovery Services Revenue Market Share by Application (2026-2031)
Table 33. North America Therapeutic Antibody Discovery Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Therapeutic Antibody Discovery Services Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Therapeutic Antibody Discovery Services Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Therapeutic Antibody Discovery Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Therapeutic Antibody Discovery Services Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Therapeutic Antibody Discovery Services Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Therapeutic Antibody Discovery Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Therapeutic Antibody Discovery Services Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Therapeutic Antibody Discovery Services Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Therapeutic Antibody Discovery Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Therapeutic Antibody Discovery Services Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Therapeutic Antibody Discovery Services Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Therapeutic Antibody Discovery Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Therapeutic Antibody Discovery Services Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Therapeutic Antibody Discovery Services Market Size by Country (2026-2031) & (US$ Million)
Table 48. Biocytogen Company Details
Table 49. Biocytogen Business Overview
Table 50. Biocytogen Therapeutic Antibody Discovery Services Product
Table 51. Biocytogen Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 52. Biocytogen Recent Development
Table 53. Charles River Laboratories Company Details
Table 54. Charles River Laboratories Business Overview
Table 55. Charles River Laboratories Therapeutic Antibody Discovery Services Product
Table 56. Charles River Laboratories Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 57. Charles River Laboratories Recent Development
Table 58. Abcam Company Details
Table 59. Abcam Business Overview
Table 60. Abcam Therapeutic Antibody Discovery Services Product
Table 61. Abcam Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 62. Abcam Recent Development
Table 63. Alloy Therapeutics Company Details
Table 64. Alloy Therapeutics Business Overview
Table 65. Alloy Therapeutics Therapeutic Antibody Discovery Services Product
Table 66. Alloy Therapeutics Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 67. Alloy Therapeutics Recent Development
Table 68. Creative Biolabs Company Details
Table 69. Creative Biolabs Business Overview
Table 70. Creative Biolabs Therapeutic Antibody Discovery Services Product
Table 71. Creative Biolabs Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 72. Creative Biolabs Recent Development
Table 73. Twist Bioscience Company Details
Table 74. Twist Bioscience Business Overview
Table 75. Twist Bioscience Therapeutic Antibody Discovery Services Product
Table 76. Twist Bioscience Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 77. Twist Bioscience Recent Development
Table 78. Rapid Novor Company Details
Table 79. Rapid Novor Business Overview
Table 80. Rapid Novor Therapeutic Antibody Discovery Services Product
Table 81. Rapid Novor Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 82. Rapid Novor Recent Development
Table 83. Curia Company Details
Table 84. Curia Business Overview
Table 85. Curia Therapeutic Antibody Discovery Services Product
Table 86. Curia Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 87. Curia Recent Development
Table 88. AlivaMab Biologics Company Details
Table 89. AlivaMab Biologics Business Overview
Table 90. AlivaMab Biologics Therapeutic Antibody Discovery Services Product
Table 91. AlivaMab Biologics Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 92. AlivaMab Biologics Recent Development
Table 93. Integrated DNA Technologies Company Details
Table 94. Integrated DNA Technologies Business Overview
Table 95. Integrated DNA Technologies Therapeutic Antibody Discovery Services Product
Table 96. Integrated DNA Technologies Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 97. Integrated DNA Technologies Recent Development
Table 98. Antibody Solutions Company Details
Table 99. Antibody Solutions Business Overview
Table 100. Antibody Solutions Therapeutic Antibody Discovery Services Product
Table 101. Antibody Solutions Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 102. Antibody Solutions Recent Development
Table 103. Eurofins Discovery Company Details
Table 104. Eurofins Discovery Business Overview
Table 105. Eurofins Discovery Therapeutic Antibody Discovery Services Product
Table 106. Eurofins Discovery Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 107. Eurofins Discovery Recent Development
Table 108. GenScript Company Details
Table 109. GenScript Business Overview
Table 110. GenScript Therapeutic Antibody Discovery Services Product
Table 111. GenScript Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 112. GenScript Recent Development
Table 113. Evotec Company Details
Table 114. Evotec Business Overview
Table 115. Evotec Therapeutic Antibody Discovery Services Product
Table 116. Evotec Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 117. Evotec Recent Development
Table 118. Aurigene Pharmaceutical Services Company Details
Table 119. Aurigene Pharmaceutical Services Business Overview
Table 120. Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Product
Table 121. Aurigene Pharmaceutical Services Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 122. Aurigene Pharmaceutical Services Recent Development
Table 123. Yumab Company Details
Table 124. Yumab Business Overview
Table 125. Yumab Therapeutic Antibody Discovery Services Product
Table 126. Yumab Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 127. Yumab Recent Development
Table 128. Creative Bioarray Company Details
Table 129. Creative Bioarray Business Overview
Table 130. Creative Bioarray Therapeutic Antibody Discovery Services Product
Table 131. Creative Bioarray Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 132. Creative Bioarray Recent Development
Table 133. CD ComputaBio Company Details
Table 134. CD ComputaBio Business Overview
Table 135. CD ComputaBio Therapeutic Antibody Discovery Services Product
Table 136. CD ComputaBio Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 137. CD ComputaBio Recent Development
Table 138. Biomolecular Discovery Services Company Details
Table 139. Biomolecular Discovery Services Business Overview
Table 140. Biomolecular Discovery Services Therapeutic Antibody Discovery Services Product
Table 141. Biomolecular Discovery Services Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 142. Biomolecular Discovery Services Recent Development
Table 143. ProteoGenix Company Details
Table 144. ProteoGenix Business Overview
Table 145. ProteoGenix Therapeutic Antibody Discovery Services Product
Table 146. ProteoGenix Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 147. ProteoGenix Recent Development
Table 148. Sichuan NB Biolab Company Details
Table 149. Sichuan NB Biolab Business Overview
Table 150. Sichuan NB Biolab Therapeutic Antibody Discovery Services Product
Table 151. Sichuan NB Biolab Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 152. Sichuan NB Biolab Recent Development
Table 153. Viva Biotech Company Details
Table 154. Viva Biotech Business Overview
Table 155. Viva Biotech Therapeutic Antibody Discovery Services Product
Table 156. Viva Biotech Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 157. Viva Biotech Recent Development
Table 158. SAFE Pharmaceutical Technology Company Details
Table 159. SAFE Pharmaceutical Technology Business Overview
Table 160. SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Product
Table 161. SAFE Pharmaceutical Technology Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 162. SAFE Pharmaceutical Technology Recent Development
Table 163. Shanghai Medicilon Company Details
Table 164. Shanghai Medicilon Business Overview
Table 165. Shanghai Medicilon Therapeutic Antibody Discovery Services Product
Table 166. Shanghai Medicilon Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 167. Shanghai Medicilon Recent Development
Table 168. WuXi Biologics Company Details
Table 169. WuXi Biologics Business Overview
Table 170. WuXi Biologics Therapeutic Antibody Discovery Services Product
Table 171. WuXi Biologics Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 172. WuXi Biologics Recent Development
Table 173. XtalPi Company Details
Table 174. XtalPi Business Overview
Table 175. XtalPi Therapeutic Antibody Discovery Services Product
Table 176. XtalPi Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 177. XtalPi Recent Development
Table 178. Detaibio Company Details
Table 179. Detaibio Business Overview
Table 180. Detaibio Therapeutic Antibody Discovery Services Product
Table 181. Detaibio Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 182. Detaibio Recent Development
Table 183. Cusabio Company Details
Table 184. Cusabio Business Overview
Table 185. Cusabio Therapeutic Antibody Discovery Services Product
Table 186. Cusabio Revenue in Therapeutic Antibody Discovery Services Business (2020-2025) & (US$ Million)
Table 187. Cusabio Recent Development
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report


List of Figures
Figure 1. Therapeutic Antibody Discovery Services Picture
Figure 2. Global Therapeutic Antibody Discovery Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Therapeutic Antibody Discovery Services Market Share by Type: 2024 VS 2031
Figure 4. Discovery of CAR-T Antibody Drugs Features
Figure 5. Discovery of Monoclonal Antibody Drugs Features
Figure 6. Discovery of ADC Antibody Drugs Features
Figure 7. Others Features
Figure 8. Global Therapeutic Antibody Discovery Services Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Therapeutic Antibody Discovery Services Market Share by Application: 2024 VS 2031
Figure 10. Biotechnology Case Studies
Figure 11. Medical Case Studies
Figure 12. University Case Studies
Figure 13. Others Case Studies
Figure 14. Therapeutic Antibody Discovery Services Report Years Considered
Figure 15. Global Therapeutic Antibody Discovery Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Therapeutic Antibody Discovery Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Therapeutic Antibody Discovery Services Market Share by Region: 2024 VS 2031
Figure 18. Global Therapeutic Antibody Discovery Services Market Share by Players in 2024
Figure 19. Global Top Therapeutic Antibody Discovery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Antibody Discovery Services as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Therapeutic Antibody Discovery Services Revenue in 2024
Figure 21. North America Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Therapeutic Antibody Discovery Services Market Share by Country (2020-2031)
Figure 23. United States Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Therapeutic Antibody Discovery Services Market Share by Country (2020-2031)
Figure 27. Germany Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Therapeutic Antibody Discovery Services Market Share by Region (2020-2031)
Figure 35. China Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Therapeutic Antibody Discovery Services Market Share by Country (2020-2031)
Figure 43. Mexico Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Therapeutic Antibody Discovery Services Market Share by Country (2020-2031)
Figure 47. Turkey Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Therapeutic Antibody Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Biocytogen Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 51. Charles River Laboratories Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 52. Abcam Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 53. Alloy Therapeutics Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 54. Creative Biolabs Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 55. Twist Bioscience Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 56. Rapid Novor Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 57. Curia Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 58. AlivaMab Biologics Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 59. Integrated DNA Technologies Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 60. Antibody Solutions Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 61. Eurofins Discovery Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 62. GenScript Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 63. Evotec Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 64. Aurigene Pharmaceutical Services Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 65. Yumab Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 66. Creative Bioarray Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 67. CD ComputaBio Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 68. Biomolecular Discovery Services Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 69. ProteoGenix Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 70. Sichuan NB Biolab Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 71. Viva Biotech Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 72. SAFE Pharmaceutical Technology Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 73. Shanghai Medicilon Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 74. WuXi Biologics Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 75. XtalPi Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 76. Detaibio Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 77. Cusabio Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2020-2025)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies